₹1303.85
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 7 % |
3 Month Return | -3.06 % |
1 Year Return | + 76.73 % |
Market Stats | |
Previous Close | ₹1,329.40 |
Open | ₹1,330.00 |
Volume | 7,600.00 |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹1,253.49Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹1,253.49 Cr |
P/B Ratio | 6.26 |
EPS | 9.3 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
![]() | NA | ₹1,253.49 Cr | 301.94% | 0.54 | ₹30 Cr | ₹227 Cr |
![]() | BUY | ₹24,251.56 Cr | 13.4% | 0.53 | NA | NA |
![]() | NA | ₹531.11 Cr | 229.99% | 0.66 | ₹19 Cr | ₹251 Cr |
![]() | BUY | ₹10,461.37 Cr | 2.81% | 0.50 | NA | NA |
![]() | NA | ₹1,037.27 Cr | 301.68% | 0.64 | ₹10 Cr | ₹64 Cr |
Organisation | Beta Drugs Ltd |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Beta Drugs Ltd
Despite recent weakness in Beta Drugs Ltd's stock, the company's financials look strong. Return on equity (ROE), net profit, earnings growth, and dividend policy are discussed as important factors for shareholders to consider.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 7 days, BETA stock has moved up by 3.7%
Best in 3 Years
In the last 3 years, BETA has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Against Peers
In the last 1 year, Zydus Lifesciences Ltd has given 87.2% return, outperforming this stock by 5.6%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 66.73% of holdings in Mar 2024 quarter
FII Holding Unchanged
Foreign Institutions holdings remained unchanged at 0.32% of holdings in Mar 2024 quarter
Retail Holding Down
Retail Investor have decreased holdings from 32.92% to 32.88% in Mar 2024 quarter
2023 | Y/Y Change | |
---|---|---|
Total Assets | ₹134.04Cr | ↑20.87% |
Total Liabilities | ₹37.79Cr | ↑13.01% |
2023 | Y/Y Change | |
---|---|---|
Operating Cash Flow | ₹10.23Cr | ↓45.47% |
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 66.73% | 0.00 | |
Foreign Institutions | 0.32% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 32.88% | 0.00 | |
Others | 0.06% | 0.00 |
Bearish
Neutral
Bullish
Beta Drugs Ltd is currently in a Bullish trading position according to technical analysis indicators.
Beta Drugs Ltd (BETA) share price today is ₹1303.85
Beta Drugs Ltd is listed on NSE
Beta Drugs Ltd is not listed on BSE
Today’s traded volume of Beta Drugs Ltd(BETA) is 7,600.00.
Today’s market capitalisation of Beta Drugs Ltd(BETA) is ₹1253.49Cr.
Beta Drugs Ltd(BETA | Price |
---|---|
52 Week High | ₹1595 |
52 Week Low | ₹728 |
Beta Drugs Ltd(BETA) share price is ₹1303.85. It is down -18.25% from its 52 Week High price of ₹1595
Beta Drugs Ltd(BETA) share price is ₹1303.85. It is up 79.10% from its 52 Week Low price of ₹728
Beta Drugs Ltd(BETA | Returns |
---|---|
1 Day Returns | -25.55% |
1 Month Returns | 7% |
3 Month Returns | -3.06% |
1 Year Returns | 76.73% |